Skip the navigation bar.
NARPD  Logo. Go to home page.
Home
About
Events
Members Pages
Professional
Links
Join Us
Sales
Contact

Make a donation

Large print?

 

Final Programme

Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
St Catherine’s College, Oxford, UK
14-16 July 2003

Conference Details

Monday    Tuesday   Wednesday

Monday 14 July

11.30

REGISTRATION STARTS
     

13.00

LUNCH (13.00-14.00)
          

 

Chairs: Maureen Owen (Oxford, UK)/Graham Russell (Oxford, UK)

14.00

Introduction and Welcome
Graham Russell (Oxford, UK)

Recent advances in osteoclast biology

14.05

Jack Martin (Melbourne, Australia): Recent advances in cell biology

14.45

Philippa Hulley (Cape Town, South Africa): Osteoblast signalling and the effect of glucocorticoids

15.20

TEA
     

 

Osteoporosis
Chairs: Juliet Compston (Cambridge, UK)/John Wass (Oxford, UK)

15.40

Steven Cummings (San Francisco CA, USA): Osteoporosis: Lessons from epidemiology

16.20

Matt Brown (Oxford, UK): Genetics of osteoporosis

17.00

Richard Eastell (Sheffield, UK): Current therapy and evaluation of treatment
        

17.40

Close
       

19.00

RECEPTION AND DINNER

Tuesday 15 July

07.45

BREAKFAST
    

  The RANK/RANK-ligand/OPG osteoprotegerin system
Chairs: Greg Mundy (San Antonio TX, USA)/Ian Reid (Auckland, New Zealand)

08.30

Bill Dougall (Thousand Oaks CA, USA): The biology of the RANK/RANK- Ligand/OPG osteoprotegerin system

09.10

Peter Croucher (Oxford, UK): Role in oncology and myeloma
      

09.50

COFFEE
       

 

The mevalonate pathway
Chairs: Hal Ebetino (Cincinnati OH, USA)/Jonathan Green (Basle, Switzerland)

10.20

Mike Rogers (Aberdeen, UK): Molecular mechanisms of action of bisphosphonates

10.50

Al Reszka (West Point PA, USA): Signalling pathways in osteoclasts

11.20

Ross Garrett (San Antonio TX, USA): Statins as bone anabolics

12.00

Eric Niesor (Geneva, Switzerland): Apomine and BP esters
     

12.45

LUNCH (12.45-13.30)
    

 

Bone oncology
Chairs: Nick Athanasou (Oxford, UK)/Jack Martin (Melbourne, Australia)

13.30

Rob Coleman (Sheffield, UK): Clinical concepts and current therapies

14.10

Greg Mundy (San Antonio TX, USA): Mechanisms, mediators and models
       

 

Steroid receptors and tissue specificity: Oestrogens and SERMs
Chairs: Jonathan Tobias (Bristol, UK)/tbc

14.50

David Thompson (Groton CT, USA): Pharmacology of SERMs
    

 

TEA
      

15.30

Steroid receptors and tissue specificity: Glucocorticoids
Chairs: Stephen Krane (Boston MA, USA)/Ed Nemeth (Toronto, Canada)

16.00

Rod Flower (London, UK): Pharmacological approaches to glucocorticoid receptors

 

Regulatory mechanisms in calcium metabolism

16.40

Raj Thakker (Oxford, UK): Lessons from genetic disorders
        

17.20

Close
       

19.00

DINNER


Monday    Tuesday   Wednesday

 

 


Page Footer.